0001144204-12-001442.txt : 20120109
0001144204-12-001442.hdr.sgml : 20120109
20120109202754
ACCESSION NUMBER: 0001144204-12-001442
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20111229
FILED AS OF DATE: 20120109
DATE AS OF CHANGE: 20120109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MANHATTAN PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001001316
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 363898269
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 810 SEVENTH AVENUE
STREET 2: 4TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: (212) 582-3950
MAIL ADDRESS:
STREET 1: 810 SEVENTH AVENUE
STREET 2: 4TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
FORMER COMPANY:
FORMER CONFORMED NAME: ATLANTIC TECHNOLOGY VENTURES INC
DATE OF NAME CHANGE: 20000330
FORMER COMPANY:
FORMER CONFORMED NAME: ATLANTIC PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19960703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WEISS MICHAEL S
CENTRAL INDEX KEY: 0001038977
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32639
FILM NUMBER: 12518577
MAIL ADDRESS:
STREET 1: 750 LEXINGTON AVE
CITY: NEW YORK
STATE: NY
ZIP: 10022
3
1
v245089_3.xml
OWNERSHIP DOCUMENT
X0204
3
2011-12-29
0
0001001316
MANHATTAN PHARMACEUTICALS INC
MHAN
0001038977
WEISS MICHAEL S
787 SEVENTH AVE, 48TH FLOOR
NEW YORK
NY
10019
1
1
1
0
See Remarks
Common Stock
7500000
D
Series A Preferred Stock
112500
D
Series A Preferred Stock
284013
I
Mr. Weiss is a principal of Opus Point Partners, LLC
Warrants to purchase Common Stock
0.04
2011-12-29
2016-12-29
Common Stock
1875000
D
Mr. Weiss beneficially owns 112,500 shares of Registrant's Preferred Stock, which votes with the Common Stock on an as-converted basis (each share of Preferred Stock converts into 500 shares of Common Stock, provided that such conversion right is subject to sufficient available authorized shares of the registrant's common stock). The shares of Series A Preferred Stock vest as follows: 14,063 on each of November 15, 2012, November 15, 2013, November 15, 2014, and November 15, 2014; 28,123 upon the occurrence of the registrant achieving a particular market capitalization target; and 28,123 upon the occurrence of the registrant achieving a second particular market capitalization target.
Each warrant is exercisable to purchase one share of the registrant's Common Stock and is exercisable for a price of $0.04 for a period of five years.
Mr. Weiss is the managing member of Opus Point Partners, LLC ("Opus Point"), and thus may be deemed to beneficially owned such shares of Series A Preferred Stock.
Executive Chairman, Interim CEO and President.
/s/ Michael S. Weiss
2012-01-09